Do testosterone levels have prognostic significance in patients with metastatic prostate cancer treated with combined androgen blockade?

Int J Urol. 2015 Jan;22(1):132-3. doi: 10.1111/iju.12623. Epub 2014 Sep 22.

Authors

Yosuke Yasuda¹, Yasuhisa Fujii, Takeshi Yuasa, Shinya Yamamoto, Junji Yonese, Iwao Fukui

Affiliation

¹ Department of Urology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.

PMID: 25243521
DOI: 10.1111/iju.12623

No abstract available

MeSH terms

Aged
Aged, 80 and over
Androgen Antagonists / therapeutic use*
Humans
Male
Middle Aged
Prognosis
Prostatic Neoplasms / blood
Prostatic Neoplasms / drug therapy
Prostatic Neoplasms / pathology*
Retrospective Studies
Survival Analysis
Testosterone / blood*

Substances

Androgen Antagonists
Testosterone